Xiaohongshu: secondary sales as a valuation ladder

The situation

Xiaohongshu (known internationally as RedNote), the Chinese social-commerce platform, took an unusual path to a higher valuation between 2024 and 2025. Instead of a single large primary funding round announced with a headline number — the way most of the case studies on this site are priced — its valuation climbed through a sequence of separate secondary share sales.

How the deal worked

Xiaohongshu's last primary funding round, in 2024, valued the company at around $17 billion. From there, reported secondary transactions moved the implied valuation to $20 billion by January 2025, $26 billion by June 2025, $31 billion by September 2025, and — most recently reported — as high as $50 billion in a late-2025 secondary share sale. Each transaction was existing shares changing hands between investors, not new capital raised by the company, yet each one reset the market's reference price for the next.

The company has reported strong underlying growth behind that repricing — Sacra estimated roughly $4.8 billion in 2024 revenue, up 30% year over year, with the company telling shareholders it expected around $3 billion in profit for 2025. Xiaohongshu has also been reported to be preparing a confidential IPO filing in Hong Kong.

The outcome

By the time of a formal IPO process, Xiaohongshu's valuation had already effectively been "discovered" step by step through the secondary market, rather than being set fresh by IPO bankers with limited recent pricing history to reference. Each secondary transaction functioned almost like an informal primary round, without the company needing to raise or deploy new capital along the way.

What it teaches

Price discovery in private markets doesn't require a formal primary round — a company with active, willing buyers and sellers can see its valuation repriced multiple times a year purely through secondary activity. For a company confident in its growth and not in urgent need of primary capital, that can be a lower-friction path to a market-tested valuation ahead of an eventual listing than negotiating one large new funding round.